enter the recreational pilot in Germany after it is formally launched by the new authorities. Sanity currently holds about a ten% share from the German medical cannabis industry since the 2024 legal reforms in Germany had been launched and most lately obtained a 21 million CAD investment from Organigram [NASDAQ:OGI] through their purchase of the

Article Under Review